다우존스 지수

무료로 등록하여 실시간 주식 시세, 대화형 차트, 실시간 옵션 플로우 등을 받아보세요.

등록

홈
인베스팅
주식
미국
NASDAQ
Century Therapeutics Inc (IPSC)
Century Therapeutics Inc (IPSC) 뉴스

IPSC

Century Therapeutics (IPSC)

Century Therapeutics Inc

일자:

규정 관련뉴스

텍스트 검색:

정렬 기준:

규정 외 뉴스

검색 관련기사 보기:NASDAQ:IPSC

1 2 3 4 5 6 다음 >>

일자	시간	출처	헤드라인	심볼	기업
2024/05/07	05:52	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:IPSC	Century Therapeutics Inc
2024/04/23	20:00	GlobeNewswire Inc.	Century Therapeutics to Present at Chardan’s 8th Annual Genetic Medicines and Cell Therapy Manufacturing Summit	NASDAQ:IPSC	Century Therapeutics Inc
2024/04/11	20:00	GlobeNewswire Inc.	Century Therapeutics Strengthens Position in Autoimmune Disease with Strategic Pipeline Expansion Supported by $60 Million Private Placement and Acquisition of Clade Therapeutics	NASDAQ:IPSC	Century Therapeutics Inc
2024/04/09	05:05	GlobeNewswire Inc.	Century Therapeutics Presents New Preclinical Data Highlighting iPSC-derived Cell Therapy Platform Technology at the 2024 American Association for Cancer Research (AACR) Annual Meeting	NASDAQ:IPSC	Century Therapeutics Inc
2024/03/25	20:00	GlobeNewswire Inc.	Sagimet Biosciences Announces Appointment of Tim Walbert and Paul Hoelscher to its Board of Directors	NASDAQ:IPSC	Century Therapeutics Inc
2024/03/19	20:00	GlobeNewswire Inc.	Century Therapeutics to Present at the H.C. Wainwright 2nd Annual Cell Therapy Virtual Conference	NASDAQ:IPSC	Century Therapeutics Inc
2024/03/14	20:30	GlobeNewswire Inc.	Century Therapeutics Reports Full Year 2023 Financial Results and Provides Business Updates	NASDAQ:IPSC	Century Therapeutics Inc
2024/03/09	08:29	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:IPSC	Century Therapeutics Inc
2024/03/08	06:40	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:IPSC	Century Therapeutics Inc
2024/03/07	06:19	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:IPSC	Century Therapeutics Inc
2024/03/06	08:03	GlobeNewswire Inc.	Century Therapeutics Announces Six Upcoming Poster Presentations at the 2024 American Association for Cancer Research (AACR) Annual Meeting	NASDAQ:IPSC	Century Therapeutics Inc
2024/02/22	06:10	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:IPSC	Century Therapeutics Inc
2024/02/22	03:04	Edgar (US Regulatory)	Form 144/A - Report of proposed sale of securities: [Amend]	NASDAQ:IPSC	Century Therapeutics Inc
2024/02/17	06:18	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:IPSC	Century Therapeutics Inc
2024/02/08	07:21	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:IPSC	Century Therapeutics Inc
2024/02/08	07:21	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:IPSC	Century Therapeutics Inc
2024/02/07	06:25	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:IPSC	Century Therapeutics Inc
2024/02/06	05:23	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:IPSC	Century Therapeutics Inc
2024/02/01	21:00	GlobeNewswire Inc.	Century Therapeutics to Present at the Guggenheim Healthcare Talks 6th Annual Biotechnology Conference	NASDAQ:IPSC	Century Therapeutics Inc
2024/01/20	07:03	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:IPSC	Century Therapeutics Inc
2023/12/12	00:30	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:IPSC	Century Therapeutics Inc
2023/12/10	02:00	GlobeNewswire Inc.	Century Therapeutics Presents Initial Data from CNTY-101 Phase 1 ELiPSE-1 Trial Supporting the Potential for a Multi-Dosing Strategy for CAR iNK Enabled by Allo-Evasion™ Edits	NASDAQ:IPSC	Century Therapeutics Inc
2023/12/07	06:07	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:IPSC	Century Therapeutics Inc
2023/12/07	06:06	Edgar (US Regulatory)	Form 3 - Initial statement of beneficial ownership of securities	NASDAQ:IPSC	Century Therapeutics Inc
2023/12/06	21:46	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:IPSC	Century Therapeutics Inc
2023/12/06	21:30	GlobeNewswire Inc.	Century Therapeutics to Host Conference Call to Discuss Preliminary Clinical Data from Phase 1 ELiPSE-1 trial of CNTY-101 in Relapsed or Refractory B-cell Lymphomas and Planned Phase 1 Study in Systemic Lupus Erythematosus	NASDAQ:IPSC	Century Therapeutics Inc
2023/12/06	21:30	GlobeNewswire Inc.	Century Therapeutics Receives FDA Clearance of IND Application for CNTY-101 in Systemic Lupus Erythematosus	NASDAQ:IPSC	Century Therapeutics Inc
2023/11/21	21:00	GlobeNewswire Inc.	Century Therapeutics to Present at the Piper Sandler 35th Annual Healthcare Conference	NASDAQ:IPSC	Century Therapeutics Inc
2023/11/09	21:56	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:IPSC	Century Therapeutics Inc
2023/11/09	21:01	GlobeNewswire Inc.	Century Therapeutics Reports Third Quarter 2023 Financial Results and Provides Business Updates	NASDAQ:IPSC	Century Therapeutics Inc

검색 관련기사 보기:NASDAQ:IPSC

1 2 3 4 5 6 다음 >>

Financial Select Sector

Invesco QQQ Trust Series 1

US Dollar vs Sterling

American Express

Energy Select Sector SPDR

Health Care Select Sector

Delayed Upgrade Clock

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관